Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2022 Earnings Call Transcript

And I remember, and I say the story often, we were sitting at dinner in a month of December with a physician talking about buying a system. And at the time that we were having dinner before we took our first bite, his CPA called him and was telling him about his financial situation and is there something that he could buy. And he says, well, I’m just sitting with the Sensus guys now talking about buying a machine. And you could hear the CPA at the end of the round say, buy 2. So we only sold one, but the CPA said, buy 2, and that’s because there was so much money being made that the guy needed a tax deduction. So that’s where it is with the fair market value lease. It’s been a tremendous tool for us. It’s a tremendous topic of conversation.

But again, when push comes to shove, the majority of these doctors are buying in cash.

Anthony Vendetti: Okay. And yes, no, I know Section 179 always helps out with fourth quarter sales. In terms of China because I know that, that’s been sort of volatile on a quarterly basis. Were there any sales to China at all this quarter or no?

Joseph Sardano: Yes. We announced that we had 6 systems shipped to China. And overall for the year, we had our best year of all selling — sending 16 units to Asia altogether. Now there was one in Korea and Taiwan was another place where we sold the unit. So you had 14 units to China, 16 units overall to Asia. So that’s a very good year. We — and keep in mind that for the entire year, especially in China, you have the COVID problem that really locked everything up there. That’s starting to open up. As we understand, China opened up from COVID just prior to their new year, which allowed a lot of their citizens to be traveling overseas, of which many came to the United States. So if China remains open, which we think it will, we are hoping to do even better in Asia for 2023, but that’s a good business for us.

Anthony Vendetti: Okay. Great. And then last question on the Silk laser hair removal system. I know you’ve just introduced that. Do you have any feedback in terms of orders? Can you talk about that a little bit?

Joseph Sardano: Yes. I mean the feedback has been very, very positive from the initial introduction at the Fall Clinical in Las Vegas in October. So we’re seeing some good volume that’s being generated with our prospect base. And now that we’ve hired what we consider a real specialty guy who’s going to drive our aesthetics business, I think that we’re going to be successful with the product because it is unique. It does have multiple energies that can be used simultaneously. It is portable. It is very cost effective at a low range as far as the cost, and without consumables, which is exactly what the physicians are requesting. So I think that as we become more known as we start to show it more, I think that we’re going to be more going to be selling more systems.

We will have several units available at the American Academy of Dermatology, the upcoming meeting this weekend. It’s going to be displayed following 2 weeks later at the Fall or the Winter clinical, it will also be displayed. And so as we gain exposure, I think that we’re going to see some sales coming about. So we’re excited about it.

Operator: That’s all the time we have for questions today. And this concludes our question-and-answer session. I’d like to turn the conference back over to Joe Sardano for closing remarks.